Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
Photoactivatable Pt(IV) anticancer prodrugs with the structure of [PtIV(N1)(N2)(L1)(L2)(A1)(A2)], where N1 and N2 are non-leaving nitrogen donor ligands, L1 and L2 are leaving ligands, and A1 and A2 are axial ligands, have attracted increasing attention due to their promising photo-cytotoxicity even...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2022-06-01
|
| Series: | Frontiers in Chemistry |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fchem.2022.876410/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
